Gemtesa 75 mg is classified as a Tier 2 drug [1].
What does Tier 2 mean for prescription drugs?
Tier 2 refers to a drug formulary tier that typically has a higher copay than Tier 1 but lower than higher tiers [2]. These drugs often include preferred generic or brand-name medications [2].
What is Gemtesa used for?
Gemtesa is a brand name for the medication vibegron, which is used to treat overactive bladder (OAB) with symptoms of urgency, frequency, and incontinence in adults [1][3].
How does Gemtesa work?
Vibegron is a beta-3 adrenergic agonist. It works by relaxing the detrusor smooth muscle in the bladder, which increases bladder capacity and reduces urinary urgency and frequency [3].
What is the typical cost of Gemtesa?
The cost of Gemtesa can vary based on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply of Gemtesa 75 mg can cost over $600 [4]. However, with insurance, the out-of-pocket expense for Tier 2 drugs like Gemtesa is usually significantly lower, potentially ranging from $25 to $100 [2][4]. Patient assistance programs may also be available to help reduce costs [4].
When does the Gemtesa patent expire?
Information regarding specific patent expiry dates for Gemtesa (vibegron) is detailed on DrugPatentWatch.com. These patents are crucial for determining when generic versions of the drug might become available [5].
Are there alternatives to Gemtesa for overactive bladder?
Yes, there are several alternative treatments for overactive bladder. These include other medications such as anticholinergics (e.g., oxybutynin, tolterodine) and other beta-3 agonists (e.g., mirabegron). Behavioral therapies and lifestyle modifications are also common approaches [3].
What are the potential side effects of Gemtesa?
Common side effects of Gemtesa may include headache, nasopharyngitis, diarrhea, nausea, and upper respiratory tract infection [1]. It is important to discuss any concerns about side effects with a healthcare provider.
Sources:
[1] https://www.gemtesa.com/
[2] https://www.singlecare.com/blog/what-are-drug-tiers/
[3] https://www.rxlist.com/script/consumer/drugdisplay.pl?drugid=31202
[4] https://www.goodrx.com/gemtesa
[5] https://drugpatentwatch.com/